Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
about
Distilling complexity to advance cardiac tissue engineeringHuman Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingYoung at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellshiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineG-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease ModelingInduced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesNanopatterned Human iPSC-Based Model of a Dystrophin-Null Cardiomyopathic PhenotypeParkinson's disease proteins: Novel mitochondrial targets for cardioprotectionInduced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discoveryCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsReprogramming and transdifferentiation for cardiovascular development and regenerative medicine: where do we stand?Induced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningHuman-induced pluripotent stem cell models of inherited cardiomyopathiesModelling human disease with pluripotent stem cellsMitoconfusion: noncanonical functioning of dynamism factors in static mitochondria of the heartCalcium signalling of human pluripotent stem cell-derived cardiomyocytesEndothelial cells derived from nuclear reprogrammingClinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem CellsMaturation status of sarcomere structure and function in human iPSC-derived cardiac myocytesGeneration of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring ContractilityAtomic force mechanobiology of pluripotent stem cell-derived cardiomyocytesGeneration of highly purified human cardiomyocytes from peripheral blood mononuclear cell-derived induced pluripotent stem cellsMutation-Specific Phenotypes in hiPSC-Derived Cardiomyocytes Carrying Either Myosin-Binding Protein C Or α-Tropomyosin Mutation for Hypertrophic Cardiomyopathy.Pitx2c is reactivated in the failing myocardium and stimulates myf5 expression in cultured cardiomyocytesIdentification and purification of human induced pluripotent stem cell-derived atrial-like cardiomyocytes based on sarcolipin expressionGeneration and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cellsGenetics and disease of ventricular muscle.Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular TachycardiaKey Challenges and Opportunities Associated with the Use of In Vitro Models to Detect Human DILI: Integrated Risk Assessment and Mitigation PlansTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineInherited heart disease - what can we expect from the second decade of human iPS cell research?Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypesInduced pluripotent stem cell potential in medicine, specifically focused on reproductive medicinehiPSC Modeling of Inherited CardiomyopathiesStudy familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cellsModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesAbnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cellsCorrection of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy.CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.
P2860
Q26747338-49C8426C-CBE1-4C43-A956-049870A8F220Q26750618-30017B57-25F4-466C-AE74-3D9B9385FFC8Q26750663-8737306C-79F1-410F-9207-F2A0C7969565Q26751506-222CB2E4-37D6-4254-A0DE-A8632A8B33F5Q26772221-19E3E109-A533-4B34-B0A1-3F8BCFBEED12Q26775061-BE1448FD-01B9-4218-8B2F-3D95F40434BAQ26779454-AE822A23-D2C7-4AEF-99B6-09B3F200E272Q26781796-1BD3CF2E-149A-4962-984B-1E2EC3280C59Q26781825-0FE5F7D2-58FA-44CA-9076-B35388E36C60Q26798131-ABFA847E-6FA6-40EA-AB97-2D447C650832Q26800082-2F423DB5-D33E-4DDE-9E9D-FA1752609193Q26828408-3A7B6A66-2154-4A87-A1FD-C6F549889FA1Q26852052-4A65AAD0-3E33-4625-97EA-3761EFEFBDCDQ26864380-E7154E3C-AA05-4FF0-AB08-B23B713123C8Q27001001-C4A74D95-FB2C-483E-83BA-86A32FF5F404Q27002443-FAC8B389-02FB-4970-8192-12E49BC6FE29Q27011837-FD13F171-CC06-4083-9111-0C136917DB6CQ27021919-1C04BB2D-22A7-42DE-851D-D3DBA383B231Q27024992-4524EFB8-8112-4338-A715-19029EB7A8B7Q27301480-86F1C4F7-4392-4D39-B19C-297C57C82487Q27302347-A1B68DFB-A2B6-41D3-92E5-A3AC28188362Q27307424-A398A20A-8539-4ACC-A542-9CA709233A82Q27314792-361F9F03-3444-43E3-9985-46D5E63839F8Q27318048-03F51008-122F-4B1E-A72C-46F434DB2903Q27320909-69E48743-B55E-4D1E-919A-2BE19AA3B08BQ27333621-E149FE44-03A5-47CA-B3A2-A3154AB18707Q27691994-08B04D4E-FC9F-4219-A989-C4E46B449D48Q28067569-AFB6148D-9F79-4060-9782-76C900ADF3F5Q28075991-198CCD53-E48F-4C04-9099-22F8F091467EQ28076397-CEC1CE42-D181-40CE-A38E-DF1F1A28CB70Q28079217-3B67DD64-088E-4C37-A811-F3CC9B89DAD7Q28081697-7383CD92-0FD4-4854-BD3D-507A02B02D4BQ28083057-0EAA55D0-F08D-47AC-87A4-06F385BC13A4Q28240320-F20392D7-5C92-4CF0-90CF-23645BB31BB5Q28247689-CF37EC0C-FA1C-45FB-9C89-FD0FB35FAC7AQ28255887-74ADE34F-4D43-488A-884D-DCD7DA3C820BQ28282675-2D800C9E-4CE0-46BF-B77A-AF577F288C53Q30411331-43B5120A-2FC4-495F-8E8C-DDF2BCE1D922Q30557177-A26E2273-394C-456A-8AA0-921C679EAF98Q30558954-73B4A70E-0E41-4FF3-981B-CB6445B14A21
P2860
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Patient-specific induced pluri ...... milial dilated cardiomyopathy.
@ast
Patient-specific induced pluri ...... milial dilated cardiomyopathy.
@en
type
label
Patient-specific induced pluri ...... milial dilated cardiomyopathy.
@ast
Patient-specific induced pluri ...... milial dilated cardiomyopathy.
@en
prefLabel
Patient-specific induced pluri ...... milial dilated cardiomyopathy.
@ast
Patient-specific induced pluri ...... milial dilated cardiomyopathy.
@en
P2093
P2860
P50
P1476
Patient-specific induced pluri ...... amilial dilated cardiomyopathy
@en
P2093
Aleksandra Pavlovic
Andrew Lee
Enrique G Navarrete
Euan A Ashley
Jianwei Liu
Masayuki Yazawa
Michael P Snyder
Michael T Longaker
Ricardo E Dolmetsch
P2860
P304
P356
10.1126/SCITRANSLMED.3003552
P407
P50
P577
2012-04-01T00:00:00Z